FundedIQ
Biotechnology

Ourobio: Funding, Investors & Team (Sep 2026)

Our mission is to develop cutting-edge, bio-based technologies to accelerate decarbonization and eliminate the creation of microplastic pollution. Using engineered microorganisms, our proprietary bioprocess turns industrial byproducts into a low-footprint, a fully biodegradable polymer and performance enhancing additives simultaneously.

www.ourobio.com LinkedIn Charlottesville, United States 1-10 employees
Total raised
$150k
Rounds
1
Latest
Pre-Seed
Aug 2022

Ourobio has raised $150k across 1 funding round on record, the most recent a Pre-Seed of $150k announced in Aug 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Ourobio Company Profile and Key Stats

Total funding raised
$150k
across 1 round on record
Funding rounds on record
1
Latest funding round
Pre-Seed
$150k in Aug 2022
Employees
1-10
reported band
Headquarters
Charlottesville, United States

Latest funding round on record: Aug 2022.

Ourobio Funding Rounds

Date
Round
Amount
Pre-Seed
$150k

Ourobio Founders and Leadership Team

Name
Role
Contact
Alec Brewer
Founder
Locked

Contact details for the Ourobio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Ourobio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
5,832
$600K

Ourobio's latest round of $150k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Ourobio in Biotechnology and Charlottesville

Companies Similar to Ourobio

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Ourobio Funding FAQs

What does Ourobio do?

Our mission is to develop cutting-edge, bio-based technologies to accelerate decarbonization and eliminate the creation of microplastic pollution. Using engineered microorganisms, our proprietary bioprocess turns industrial byproducts into a low-footprint, a fully biodegradable polymer and performance enhancing additives simultaneously.

How much funding has Ourobio raised?

Ourobio has raised $150k across 1 round on record. The most recent is a Pre-Seed of $150k announced in Aug 2022.

When did Ourobio last raise funding?

Ourobio's most recent funding round on record is a Pre-Seed of $150k, announced in Aug 2022.

Who founded Ourobio?

FundedIQ lists Alec Brewer (Founder) at Ourobio.

Where is Ourobio headquartered?

Ourobio is based in Charlottesville, Virginia, United States.

How many employees does Ourobio have?

Ourobio is in the 1-10 employee band.

How does Ourobio's funding compare to other Biotechnology startups?

Ourobio's latest round of $150k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Ourobio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ourobio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.